Serum Institute of India to send 10 million doses of Covid-19 vaccine Covishield to UK: Report
- SII, the world's largest vaccine manufacturer by volume, is mass-producing AstraZeneca vaccine Covishield, developed with Oxford University
- Nearly 20.5 million residents in Britain have received the first dose of a Covid-19 vaccine so far, according to official data
The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said, news agency Reuters reports. "The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India," a UK government spokesperson told Reuters.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more